top of page

Randall Knoebel



High Reliability/Formulary Management


PharmD: Midwestern University Chicago
MPH: University of Illinois at Chicago

Residency Training

PGY1: Rush University Medical Center
PGY2 Hematology/Oncology: University of Washington

Randall Knoebel

Practice Interests

Pain management, pharmacogenomics, implementation science, quality improvement, data/analytics

Professional Affiliation

  • ICHP - Opioid Task Force Member 

  • ICHP Residency Director Network 

  • Midwest Pain Society - Educational Board Member 

  • ASHP Foundation's Research Advisory Committee 

  • ASHP Foundation's Research Grant Review Panel

Recent Publications

Academic and/or National Presentations

  • "Impact of Social Vulnerability & Opioid Overdose Deaths" Midwest Pain Society - 46th Annual Meeting - Speaker (9/2022) 

  • "The Inside Scoop From a Residency Program Director" Illinois Hospital Association - Speaker (9/2022) 

  • "Managing Drug Shortages in a Large Academic Medical Center" - UChicago Medicine Grand Rounds - Speaker (8/2022) 

  • "Value Oriented Approach to Tumor Lysis Syndrome Management" - Sanofi Expert Seminar Series - Invited Speaker (7/2022) 

  • "Case Manager Perspectives on Managing Clients with Substance Use Disorder" AIDS Foundation Chicago - Lunch & Learn - Speaker (10/2021) 

  • "Innovative Teamwork in Healthcare: Maximizing Collective Intelligence Via Collaboration Midwest Pain Society" - 45th Annual Meeting - Session Moderator (9/2021) 

  • "Immunoglobulin (Ig) Optimization Collaborative - UChicago Medicine Experience" - Vizient - Panelist (8/2021)

Current Research

  • Impact of Sedation Stewardship Program in UChicago Medicine ICUs. Research in process. 

  • Impact of Mucolytic Stewardship Program at UChicago Medicine. Research in process. 

  • Zoledronic acid use for hypercalcemia in renal insufficiency. Manuscript submitted for publication. 

  • Impact of COVID-19 Pandemic, Social Vulnerability, and Opioid Overdose Deaths in Chicago. Manuscript submitted for publication. 

  • Implementation of Pharmacogenomics in Inpatient General Medicine and Recruiting Inpatient Providers in the Use of Pharmacogenomics. Manuscript submitted for publication. 

  • Estimated environmental impact and carbon offsets of reduced frequency trastuzumab dosing. Manuscript submitted for publication. 

  • Real-world impact of a pharmacogenomics-enriched comprehensive medication management program Special Issue: Precision Medicine in Clinical Practice. Manuscript submitted for publication.

bottom of page